{"id":"https://openalex.org/W2996748732","doi":"https://doi.org/10.1016/j.jval.2019.09.142","title":"PBI38 INNOVATIVE ATMPS: MARKET ACCESS AND REIMBURSEMENT DECISIONS IN THE EU5: AVAILABILITY OR NOT, THAT IS THE QUESTION...","display_name":"PBI38 INNOVATIVE ATMPS: MARKET ACCESS AND REIMBURSEMENT DECISIONS IN THE EU5: AVAILABILITY OR NOT, THAT IS THE QUESTION...","publication_year":2019,"publication_date":"2019-11-01","ids":{"openalex":"https://openalex.org/W2996748732","doi":"https://doi.org/10.1016/j.jval.2019.09.142","mag":"2996748732"},"language":"en","primary_location":{"id":"doi:10.1016/j.jval.2019.09.142","doi":"https://doi.org/10.1016/j.jval.2019.09.142","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2019.09.142","pdf_url":"http://www.valueinhealthjournal.com/article/S1098301519325203/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.valueinhealthjournal.com/article/S1098301519325203/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024860874","display_name":"Stefan Walzer","orcid":"https://orcid.org/0000-0002-6477-0106","observed_orcids":["https://orcid.org/0000-0002-6477-0106"]},"institutions":[{"id":"https://openalex.org/I24227732","display_name":"University of Applied Sciences Ravensburg-Weingarten","ror":"https://ror.org/00s4rmz74","country_code":"DE","type":"education","lineage":["https://openalex.org/I24227732"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"S. Walzer","raw_affiliation_strings":["MArS Market Access & Pricing GmbH, State University Baden-Wuerttemberg, University of Applied Sciences Weingarten-Ravensburg, Weil am Rhein, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MArS Market Access & Pricing GmbH, State University Baden-Wuerttemberg, University of Applied Sciences Weingarten-Ravensburg, Weil am Rhein, Germany","institution_ids":["https://openalex.org/I24227732"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043460705","display_name":"Mariangela Prada","orcid":"https://orcid.org/0009-0003-2089-1672","observed_orcids":["https://orcid.org/0009-0003-2089-1672"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Prada","raw_affiliation_strings":["INTEXO Srl, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INTEXO Srl, Rome, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028628616","display_name":"I. Berard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165637","display_name":"Nextep","ror":"https://ror.org/05v7gs072","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210165637"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"I. Berard","raw_affiliation_strings":["Nextep and MEDVANCE France, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nextep and MEDVANCE France, Paris, France","institution_ids":["https://openalex.org/I4210165637"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025374018","display_name":"F. Benazet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165637","display_name":"Nextep","ror":"https://ror.org/05v7gs072","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210165637"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"F. Benazet","raw_affiliation_strings":["Nextep and MEDVANCE France, Paris, 75, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nextep and MEDVANCE France, Paris, 75, France","institution_ids":["https://openalex.org/I4210165637"]}]},{"author_position":"middle","author":{"id":null,"display_name":"W. Greenhill","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. Greenhill","raw_affiliation_strings":["Decideum and MEDVANCE UK, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Decideum and MEDVANCE UK, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010037237","display_name":"D. Martinez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107926","display_name":"Oblikue Consulting (Spain)","ror":"https://ror.org/01ksntm04","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210107926"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"D. Martinez","raw_affiliation_strings":["Oblikue Consulting S.L. and MEDVANCE Spain, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oblikue Consulting S.L. and MEDVANCE Spain, Barcelona, Spain","institution_ids":["https://openalex.org/I4210107926"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110530798","display_name":"L. Vollmer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Vollmer","raw_affiliation_strings":["MArS - Market Access & Pricing Strategy GmbH and MEDVANCE Germany, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MArS - Market Access & Pricing Strategy GmbH and MEDVANCE Germany, Tuebingen, Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2850,"currency":"USD","value_usd":2850},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":null,"first_page":"S424","last_page":"S424"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.045499999076128006,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-therapy-medicinal-products","display_name":"advanced therapy medicinal products","score":0.9520000219345093},{"id":"https://openalex.org/keywords/market-access","display_name":"market access","score":0.8930000066757202},{"id":"https://openalex.org/keywords/coverage-decisions","display_name":"reimbursement decisions","score":0.9139999747276306},{"id":"https://openalex.org/keywords/european-union","display_name":"European Union","score":0.48899999260902405},{"id":"https://openalex.org/keywords/regulatory-pathways","display_name":"regulatory pathways","score":0.45399999618530273},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.4650000035762787},{"id":"https://openalex.org/keywords/cell-therapy","display_name":"cell therapy","score":0.6930000185966492},{"id":"https://openalex.org/keywords/luxturna","display_name":"Luxturna","score":0.6370000243186951},{"id":"https://openalex.org/keywords/axicabtagene-ciloleucel","display_name":"axicabtagene ciloleucel","score":0.796999990940094},{"id":"https://openalex.org/keywords/tisagenlecleucel","display_name":"tisagenlecleucel","score":0.7369999885559082},{"id":"https://openalex.org/keywords/zalmoxis","display_name":"Zalmoxis","score":0.7250000238418579}],"concepts":[{"id":"https://openalex.org/C2779703844","wikidata":"https://www.wikidata.org/wiki/Q760125","display_name":"Reimbursement","level":3,"score":0.9292669892311096},{"id":"https://openalex.org/C145097563","wikidata":"https://www.wikidata.org/wiki/Q1148747","display_name":"Payment","level":2,"score":0.6149304509162903},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.6112045049667358},{"id":"https://openalex.org/C2780233690","wikidata":"https://www.wikidata.org/wiki/Q535347","display_name":"Transparency (behavior)","level":2,"score":0.6072747707366943},{"id":"https://openalex.org/C199776023","wikidata":"https://www.wikidata.org/wiki/Q202875","display_name":"Negotiation","level":2,"score":0.5949732661247253},{"id":"https://openalex.org/C108759981","wikidata":"https://www.wikidata.org/wiki/Q788590","display_name":"Authorization","level":2,"score":0.5835902094841003},{"id":"https://openalex.org/C2777481183","wikidata":"https://www.wikidata.org/wiki/Q6770787","display_name":"Market access","level":3,"score":0.4855196475982666},{"id":"https://openalex.org/C21333345","wikidata":"https://www.wikidata.org/wiki/Q1519843","display_name":"Health technology","level":3,"score":0.47095543146133423},{"id":"https://openalex.org/C2779256446","wikidata":"https://www.wikidata.org/wiki/Q33959","display_name":"Nice","level":2,"score":0.45056337118148804},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.3437322974205017},{"id":"https://openalex.org/C162118730","wikidata":"https://www.wikidata.org/wiki/Q1128453","display_name":"Actuarial science","level":1,"score":0.34156063199043274},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.2757799029350281},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.1338403820991516},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.10530656576156616},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.09611847996711731},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C118518473","wikidata":"https://www.wikidata.org/wiki/Q11451","display_name":"Agriculture","level":2,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jval.2019.09.142","doi":"https://doi.org/10.1016/j.jval.2019.09.142","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2019.09.142","pdf_url":"http://www.valueinhealthjournal.com/article/S1098301519325203/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jval.2019.09.142","doi":"https://doi.org/10.1016/j.jval.2019.09.142","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2019.09.142","pdf_url":"http://www.valueinhealthjournal.com/article/S1098301519325203/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3113202723","https://openalex.org/W2905980717","https://openalex.org/W2765950887","https://openalex.org/W2543913731","https://openalex.org/W2767136691","https://openalex.org/W2905887623","https://openalex.org/W2766016359","https://openalex.org/W2963516831","https://openalex.org/W2423673919","https://openalex.org/W2996716335"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-12-26T00:00:00"}